Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Post by Ticklel1ston Dec 19, 2019 11:04am
103 Views
Post# 30472557

So...Doug is hard at work for the money and shares

So...Doug is hard at work for the money and shares

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced July 9, 2019.

 

Number of shares:  3.75 million shares

Purchase price:  40 cents per share

Warrants:  3.75 million share purchase warrants to purchase 3.75 million shares

Warrant initial exercise price:  60 cents

Warrant term to expiry:  three years

Number of placees:  19 placees

Insider:  Jie Tian, 114,500

Finders' fees:  PI Financial, $10,284.40 cash and 25,711 warrants; Douglas Billings, $72,099.60 cash and 180,249 warrants

Finder's warrant initial exercise price:  60 cents

Finder's warrant term to expiry:  three-year term

Bullboard Posts